|
|
|
|
|
|
|
|
Comparing First-Line Therapies for Mucinous Ovarian or Fallopian Tube Cancer
Name of the TrialPhase III Study of Carboplatin and Paclitaxel with Versus without Bevacizumab Compared to Oxaliplatin and Capecitabine with Versus without Bevacizumab as First-Line Therapy in Patients with Newly Diagnosed Stage II-IV or Recurrent Stage I Mucinous Epithelial Ovarian or Fallopian Tube Cancer (GOG-0241). See the protocol summary.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.